Glaucoma, the second leading cause of blindness globally, affects millions and is projected to reach 111.8 million cases by ...

Over a video call, Alex Zhavoronkov holds up a small, green, diamond-shaped pill. It has been developed by his company to ...

Seasoned advisory group including RNA, translation and commercialisation luminaries.

Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...

Character Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, ...

Drug discovery is a key area for AI, given the speed at which models trained on massive datasets can tackle a variety of tasks. Last year, Nvidia said it was doubling down on AI-powered drug discovery ...

We recently compiled a list of the 10 Best Quantum Computing Stocks to Buy for 2025. In this article, we are going to take a ...

The addition of Tavros greatly expands Vividion's functional genomics expertise and capabilities, bringing proprietary methods for genomic screening that can identify new target opportunities, as well ...